THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

TWO SIGMA ADVISERS, LP's Holding History (CIK: 0001478735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 379,500 Value ($000) $7,100 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 200,300 Value ($000) $2,924 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 29,100 Value ($000) $321 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 24,700 Value ($000) $221 Avg Close $9.31 Range $8.35 - $10.90
Q2 2024
Shares 33,900 Value ($000) $287 Avg Close $9.03 Range $8.13 - $10.44
Q2 2023
Shares 94,300 Value ($000) $976 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 483,800 Value ($000) $5,249 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 1,008,600 Value ($000) $11,316 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 696,600 Value ($000) $7,064 Avg Close $9.37 Range $7.53 - $11.00
Q1 2022
Shares 10,700 Value ($000) $102 Avg Close $9.80 Range $7.71 - $13.17
Q1 2021
Shares 29,800 Value ($000) $608 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 37,000 Value ($000) $657 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 79,800 Value ($000) $1,180 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 51,400 Value ($000) $1,079 Avg Close $25.69 Range $20.17 - $31.35
Q3 2016
Shares 6,200 Value ($000) $225 Avg Close $27.84 Range $21.97 - $37.14